Panagora Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,225
Closed -$65K 2414
2017
Q3
$65K Hold
2,225
﹤0.01% 2005
2017
Q2
$58K Hold
2,225
﹤0.01% 2031
2017
Q1
$52K Hold
2,225
﹤0.01% 2014
2016
Q4
$56K Hold
2,225
﹤0.01% 2079
2016
Q3
$62K Sell
2,225
-24,581
-92% -$630K ﹤0.01% 2080
2016
Q2
$661K Sell
26,806
-43,771
-62% -$1.09M ﹤0.01% 1272
2016
Q1
$1.56M Buy
70,577
+18,764
+36% +$499K 0.01% 948
2015
Q4
$1.81M Buy
51,813
+39,092
+307% +$1.22M 0.01% 853
2015
Q3
$362K Buy
12,721
+5,528
+77% +$186K ﹤0.01% 1419
2015
Q2
$240K Sell
7,193
-56,041
-89% -$1.72M ﹤0.01% 1598
2015
Q1
$1.78M Sell
63,234
-74,647
-54% -$1.86M 0.01% 820
2014
Q4
$2.86M Sell
137,881
-70,847
-34% -$1.68M 0.01% 620
2014
Q3
$5.1M Sell
208,728
-71,927
-26% -$1.91M 0.02% 480
2014
Q2
$8.02M Sell
280,655
-1,165
-0.4% -$32.4K 0.04% 398
2014
Q1
$7.88M Buy
281,820
+97,867
+53% +$2.4M 0.04% 426
2013
Q4
$3.96M Buy
183,953
+19,685
+12% +$358K 0.02% 606
2013
Q3
$2.18M Buy
164,268
+13,875
+9% +$187K 0.01% 787
2013
Q2
$2.08M Buy
+150,393
New +$2.13M 0.01% 761

Panagora Asset Management's PMC Position: Q4 2017 in Review

Panagora Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 2,225 shares — an estimated $65K sold.

Panagora Asset Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $8.02M in Q2 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Panagora Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Panagora Asset Management sold 2,225 PharMerica Corporation shares in Q4 2017, an estimated $65K.
  • Panagora Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
  • Panagora Asset Management's PharMerica Corporation position peaked at $8.02M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.